title: Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior.
abstract: Because insulin acutely enhances the function of dopamine transporters, the tyrosine kinase receptors activated by this hormone may modulate transporter-dependent neurochemical and behavioral effects of psychoactive drugs. In this respect, we examined the effects of insulin on exocytotic monoamine release and the efficacy of the monoamine transporter blocker cocaine in rat nucleus accumbens. Whereas insulin reduced electrically evoked exocytotic [(3)H]dopamine release in nucleus accumbens slices, the hormone potentiated the release-enhancing effect of cocaine thereon. The phosphatidylinositol 3-kinase inhibitor LY294002 abolished these effects, indicating the involvement of insulin receptors. Similar insulin effects were observed on the release of [(3)H]norepinephrine in nucleus accumbens slices, but not on that of [(3)H]serotonin, and were also apparent in medial prefrontal cortex slices. As might then be expected, insulin also potentiated the dopamine and norepinephrine release-enhancing effects of the selective monoamine uptake inhibitors GBR12909 and desmethylimipramine, respectively. In subsequent behavioral experiments, we investigated the role of insulin in motor impulsivity that depends on monoamine neurotransmission in the nucleus accumbens. Intracranial administration of insulin in the nucleus accumbens alone reduced premature responses in the five-choice serial reaction time task and enhanced the stimulatory effect of peripheral cocaine administration on impulsivity, resembling the observed neurochemical effects of the hormone. In contrast, cocaine-induced locomotor activity remained unchanged by intra-accumbal insulin application. These data reveal that insulin presynaptically regulates cocaine-sensitive monoamine transporter function in the nucleus accumbens and, as a consequence, impulsivity. Therefore, insulin signaling proteins may represent targets for the treatment of inhibitory control deficits such as addictive behaviors.
authors.affiliation: Department of Anatomy and Neurosciences, VU University Medical Center, 1081 BT Amsterdam, The Netherlands. anm.schoffelmeer@vumc.nl
authors.forename: Anton N M
authors.initials: AN
authors.lastname: Schoffelmeer
authors.forename: Benjamin
authors.initials: B
authors.lastname: Drukarch
authors.forename: Taco J
authors.initials: TJ
authors.lastname: De Vries
authors.forename: François
authors.initials: F
authors.lastname: Hogenboom
authors.forename: Dustin
authors.initials: D
authors.lastname: Schetters
authors.forename: Tommy
authors.initials: T
authors.lastname: Pattij
mesh_terms: D000818:Animals; D015306:Biogenic Monoamines / Q000378:metabolism*; D003042:Cocaine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D007175:Impulsive Behavior / Q000503:physiopathology / Q000523:psychology*; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology / Q000502:physiology*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009433:Neural Inhibition / Q000187:drug effects; D050479:Neurotransmitter Transport Proteins / Q000037:antagonists & inhibitors* / Q000502:physiology; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: D015306:Biogenic Monoamines; D007328:Insulin; D050479:Neurotransmitter Transport Proteins; D003042:Cocaine; D004298:Dopamine